Cargando…
A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India
BACKGROUND: Prescription event monitoring (PEM) study is conducted worldwide. The main objective of such study is to monitor the adverse events when a drug is being prescribed in “real life clinical” settings. PEM studies are being looked upon as an essential observational tool of postmarketing surv...
Autores principales: | Hajare, Anoop, Gupta, Amandeep, Patil, Saiprasad, Krishnaprasad, K, Bhargava, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456900/ https://www.ncbi.nlm.nih.gov/pubmed/26097813 http://dx.doi.org/10.4103/2229-516X.157151 |
Ejemplares similares
-
Survival or Safety: Balancing act with Colistin
por: Patil, Saiprasad, et al.
Publicado: (2015) -
Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006) -
Polymyxin-B Combination Therapy – A Dire Need to Safeguard Our Last Hope
por: Lakhe, Maheshkumar, et al.
Publicado: (2016) -
A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin
por: Matsuda, Yoko, et al.
Publicado: (2017) -
Severe and Recurrent Hypoglycemia Caused by Garenoxacin in a Patient not Taking Hypoglycemic Drugs
por: Kondo, Manabu, et al.
Publicado: (2018)